Clinical trials
Gastroparesis trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 6 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Terminated | 12 |
| Recruiting | 9 |
| Active, not recruiting | 4 |
| Withdrawn | 4 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cairn Diagnostics | 5 |
| Indiana University | 5 |
| Johns Hopkins University | 5 |
| Mayo Clinic | 5 |
| Stanford University | 3 |
| Enterra Medical, Inc. | 2 |
| Matthew Allemang | 2 |
| Northwestern University | 2 |
| Ohio State University | 2 |
| Texas Tech University Health Sciences Center, El Paso | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastroparesis | 62 |
| Vomiting | 9 |
| Nausea | 8 |
| Diabetes Mellitus | 5 |
| Dyspepsia | 5 |
| Gastroesophageal Reflux | 3 |
| Anxiety Disorders | 2 |
| Diabetes Mellitus, Type 1 | 2 |
| Esophagitis | 2 |
| Scleroderma, Diffuse | 2 |
Trials
Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.